Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-08-008496
Filing Date
2008-11-12
Accepted
2008-11-12 14:03:38
Documents
4

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS, INC. c06286b5sv1za.htm S-1/A 2044152
2 EX-23.1 CONSENT OF KPMG LLP c06286b5exv23w1.htm EX-23.1 2680
3 GRAPHIC c06286b5c0628602.gif GRAPHIC 3768
4 GRAPHIC c06286b5c0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-08-008496.txt   2054150
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 081180098
SIC: 2834 Pharmaceutical Preparations